The evaluation of β3-ARs expression on tumour cells (CD45− CD99+ gated cells) revealed a higher percentage of β3-AR positive cells in samples derived from metastatic patients, with a significant statistical difference (Figure 5B). This evidence concerns the gene CD99 and neoplasm.